Literature DB >> 24307978

Differential diagnosis of hallucinations in a patient with myasthenia gravis.

Sami Ouanes1, Yosr Hizem, Mouna Ben Djebara, Imen Kacem, Amina Gargouri, Riadh Gouider.   

Abstract

We present the case of a 63-year-old woman with comorbidity of myasthenia gravis and psychosis. Different diagnostic hypotheses based on a review of the literature are discussed. A protracted history of physical spousal abuse, patient symptoms, and results of different investigations allowed us to conclude that the patient had a form of posttraumatic stress disorder with secondary psychotic features. Psychosis due to myasthenia gravis is rarely seen, and it remains unclear what is the pathophysiology, if any, for such an association. The present case highlights the difficulties the physician faces in disentangling psychosis as a potential manifestation of myasthenia gravis itself versus being caused by a medical side effect of treatment, or psychosis due to a distinct co-occurring neurologic or psychiatric condition.

Entities:  

Keywords:  Myasthenia gravis; hallucinations; posttraumatic stress disorder; psychosis

Year:  2013        PMID: 24307978      PMCID: PMC3849878     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  14 in total

Review 1.  [Psychosis and trauma. Theorical links between post-traumatic and psychotic symptoms].

Authors:  Y Auxéméry; G Fidelle
Journal:  Encephale       Date:  2011-02-02       Impact factor: 1.291

2.  Co-occurrence of posttraumatic stress disorder with positive psychotic symptoms in a nationally representative sample.

Authors:  Jitender Sareen; Brian J Cox; Renee D Goodwin; Gordon J G Asmundson
Journal:  J Trauma Stress       Date:  2005-08

Review 3.  [Corticosteroid-induced paranoid psychosis: case report and review of the literature].

Authors:  L Seurs; A Mierzejewska; S J Claes
Journal:  Tijdschr Psychiatr       Date:  2011

4.  Psychotic symptoms in refugees diagnosed with PTSD: a series of case reports.

Authors:  Marie Norredam; Mette Jensen; Morten Ekstrøm
Journal:  Nord J Psychiatry       Date:  2010-11-18       Impact factor: 2.202

5.  Plasma dopamine beta-hydroxylase activity in psychotic and non-psychotic post-traumatic stress disorder.

Authors:  M B Hamner; P B Gold
Journal:  Psychiatry Res       Date:  1998-02-27       Impact factor: 3.222

6.  Bromide intoxication secondary to pyridostigmine bromide therapy.

Authors:  D M Rothenberg; A S Berns; R Barkin; R H Glantz
Journal:  JAMA       Date:  1990-02-23       Impact factor: 56.272

7.  Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects.

Authors:  Frederic J Sautter; Garth Bissette; Justin Wiley; Gina Manguno-Mire; Benjamin Schoenbachler; Leann Myers; Janet E Johnson; Arleen Cerbone; Dolores Malaspina
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

Review 8.  Posttraumatic stress disorder with secondary psychotic features: neurobiological findings.

Authors:  Mario H Braakman; Frank A M Kortmann; Wim van den Brink; Robbert J Verkes
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

9.  Serum antibodies to nicotinic acetylcholine receptors in schizophrenic patients.

Authors:  S Mukherjee; S P Mahadik; A Korenovsky; H Laev; D B Schnur; R Reddy
Journal:  Schizophr Res       Date:  1994-05       Impact factor: 4.939

10.  Psychoses in three cases with myasthenia gravis and thymoma--proposal of a paraneoplastic autoimmune neuropsychiatric syndrome.

Authors:  M Musha; F Tanaka; M Ohuti
Journal:  Tohoku J Exp Med       Date:  1993-04       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.